Vibe-code rescue for Boston founders
Boston out-raises every other U.S. biotech market combined, and the current wave of funding is increasingly going to companies that blend wet-lab science with machine-learning infrastructure. That combination means more Boston-area software touches patient data, clinical trial records, or both, at exactly the moment it was built fastest, with an AI coding assistant that has no concept of a HIPAA technical safeguard. We work remotely with Boston teams on Eastern hours, no office visit required, and the same $1,500 Rapid Diagnostic, credited toward the full audit, everywhere.
The highest-consequence data category in the country, built at startup speed
Boston-area biotechs closed roughly $14.8 billion in deals across more than 320 companies in a recent year, and startups in the metro raised a full billion dollars in a single month, one of the strongest month-over-month totals in years. Our own industry pricing research separately found healthcare carries the highest average breach cost of any sector, at roughly $6.6 to $7.4 million, and the steepest per-violation civil penalty ceiling under HIPAA, up to $2.19 million per identical violation category.
Those two facts sit on top of each other in Boston more than almost anywhere else: real regulatory teeth, and a founder base moving fast enough to have skipped the review that would have caught the problem before a patient's data was ever at risk.
- A BAA is a legal trap, not paperwork. Signing one makes an engineering vendor a HIPAA business associate with direct OCR liability, independent of the client.
- AI-and-biology convergence means more model calls, not fewer. A clinical-adjacent app calling an LLM on patient-derived data needs a token-cost design pass alongside a security one.
- OCR enforcement is active, not theoretical. The agency closed a recent year with its second-highest annual settlement and civil-penalty total on record.
We assess against HIPAA's technical safeguards. We do not certify compliance.
There is no such thing as a HIPAA-certified vendor, and any firm selling one is selling marketing, not a real credential. HIPAA compliance is the covered entity's own legal obligation. What we do: a Security Rule gap assessment, remediation of what fails it, and documentation your own counsel and, where required, your BAA-covered arrangement can rely on.
Wherever the engineering task allows it, we test against de-identified or synthetic data rather than real patient records. If a BAA is genuinely unavoidable, we treat it as the real, ongoing legal exposure it is, not a formality, and we do not accept one at the Rapid Diagnostic tier.
Boston founder questions
Do you have a Boston office?
No, we're a fully remote team. Boston founders work with us over video calls, written diagnostics, and shared repos, scheduled on Eastern hours.
Can you make our app HIPAA compliant?
No, and no vendor legitimately can. HIPAA compliance is the covered entity's own legal obligation, and there is no government-issued HIPAA certification. We perform a Security Rule gap assessment, harden what fails it, and document the work, which is the engineering half of the obligation.
Will you sign a BAA?
We evaluate it case by case, with counsel, because it creates real direct liability for us under the 2013 Omnibus Rule. We avoid touching real PHI wherever the review can be done on de-identified data instead, and we do not accept a BAA at the $1,500 Rapid Diagnostic tier.
How fast can you start for a Boston-based team?
Triage usually begins within 24 to 48 hours. If a payer or hospital-system partner's review has a deadline, tell us when you reach out.
Send us the repo. We'll tell you the truth about it.
A senior engineer reads your actual code and gives you a straight assessment, on your schedule.